Abstract:Background PD-1/PD-L1 blockades have shown promising antitumor activity in clinical trials of advanced nasopharyngeal carcinoma (NPC). Being the most wildly used molecular imaging in clinic, 18F-FDG PET/CT provides multiple information of tumor biology. In this study, we investigated the association of PD-L1 expression with 18F-FDG uptake and clinical features in patients with NPC. Methods 84 patients were initially histopathologically diagnosed with NPC between December 2016 and March 2019. All tissue specimens and PET/CT images were collected before any treatment. The PD-L1 antibody we used in this investigation was SP263 (Ventana, USA). High PD-L1 expression in tumor cells (TC) or tumor-infiltrating immune cells (TIIC) was defined as≥50% of corresponding cells with membranous staining. Results The values of tumor SUVmax and TLG in patients with positive TC PD-L1 expression were significantly higher than those of negative TC PD-L1 expression (SUVmax: 10.3±4.1 vs. 6.9±3.2; P<0.001; TLG: 77.7±64.5 vs. 35.0±20.5; P<0.001), while the SUVmax values and TLG in patients with positive TIIC PD-L1 expression is lower than those of negative TIIC PD-L1 expression (SUVmax: 7.0±3.4 vs. 9.7±4.1; P=0.011; TLG: 29.1±14.4 vs. 71.3±61.2; P=0.001). Univariate analysis showed that the expression of PD-L1 in TC was associated with tumor T stage (P=0.044) but not with serum Epstein-Barr virus (EBV) load (P=0.816). On the other hand, the expression of PD-L1 in TIIC was related to both T stage (P=0.028) and serum EBV load (P=0.003). In multivariate logistic regression analysis, PD-L1 expression in TC was positively associated with tumor SUVmax (P=0.003) and TLG (P=0.001), while PD-L1 expression in TIIC was negatively associated with SUVmax (P=0.038) and serum EBV load (P=0.025). Through the ROC curve, the SUVmax cut-off value of 6.7 and the TLG cut-off value of 41.3 can be used to predict the PD-L1 status in TC with an accuracy of 78.6% and 71.4%, while the SUVmax cut-off value of 7.2 can be used to predict the PD-L1 status in TIIC with an accuracy of 72.6%. Conclusions 18F-FDG uptake with NPC lesions were positively correlated with PD-L1 expression in TC and negatively correlated with PD-L1 expression in TIIC. 18F-FDG PET / CT imaging may be useful for predicting the PD-L1 status in patients with NPC. Legal entity responsible for the study The authors. Funding Has not received any funding. Disclosure All authors have declared no conflicts of interest.

Correlation of PD-L1 Expression on Tumor Cell and Tumor Infiltrating Immune Cell with 18F-Fluorodeoxyglucose Uptake on PET/computed Tomography in Surgically Resected Pulmonary Adenocarcinoma.

Correlation Between PD-L1 Expression and 18F-FDG Uptake in Lung Adenocarcinoma

18F-FDG Maximum Standard Uptake Value Predicts PD-L1 Expression on Tumor Cells or Tumor-Infiltrating Immune Cells in Non-Small Cell Lung Cancer

Relationship between the expression of PD-L1 and 18 F-FDG uptake in pancreatic ductal adenocarcinoma

Prognostic significance of PD-L1 expression and 18 F-FDG PET/CT in surgical pulmonary squamous cell carcinoma.

[18F]-FDG PET/CT in predicting PD-L1 status in nasopharyngeal carcinoma

Negative Correlation Between 18F-RGD Uptake via PET and Tumoral PD-L1 Expression in Non-Small Cell Lung Cancer

The potential of 18F-FDG PET/CT in predicting PDL1 expression status in pulmonary lesions of untreated stage IIIB-IV non-small-cell lung cancer

Retrospective Analysis of the Predictive Value of 18F-FDG PET/CT Metabolic Parameters for PD-L1 Expression in Cervical Cancer

Sensitivity and specificity of amide proton transfer-weighted imaging for assessing programmed death-ligand 1 status in non-small cell lung cancer: a comparative study with intravoxel incoherent motion and 18 F-FDG PET

The Correlation and Overlaps Between PD-L1 Expression and Classical Genomic Aberrations in Chinese Lung Adenocarcinoma Patients: a Single Center Case Series

Association Between Histopathological Subtype, 18F-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma.

Correlation of 18F-FDG PET/CT metabolic parameters with the expression of immune biomarkers in the tumour microenvironment in lung adenocarcinoma

Is There Any Correlation Between Spectral CT Imaging Parameters and PD‐L1 Expression of Lung Adenocarcinoma?

Clinical factors associated with high PD‐L1 expression in patients with early‐stage non‐small cell lung cancer

Relationship between 18F-FDG PET/CT Semi-Quantitative Parameters and International Association for the Study of Lung Cancer, American Thoracic Society/European Respiratory Society Classification in Lung Adenocarcinomas

Relationship Between PD-L1 Expression and Molecular Aberrances in Lung Adenocarcinoma with Solid Components

Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer

Associations of Tumor PD-1 Ligands, Immunohistochemical Studies, and Textural Features in 18F-FDG PET in Squamous Cell Carcinoma of the Head and Neck

P1.03-074 Combined Use of PET/CT and Clinical Features Yields a Higher Diagnostic Rate of Mediastinal Lymph Node Metastasis in Lung Adenocarcinoma

Prognostic Value of PD-L1 Expression in Resected Lung Adenocarcinoma and Potential Molecular Mechanisms